Symbiomix Therapeutics Company
Symbiomix Therapeutics is a privately-held biopharmaceutical company that offers anti-infective drug and single dose treatment.
%20.jpg)
Founded Date:
2012
Total Funding:
$47 000 000
Investor Type:
Company
Employee Number:
11-50
Investment Stage:
N/A
Funding Status:
M&A
Number Of Exists:
Venture - Series Unknown
Technology:
Cancer
Last Funding Type:
Venture - Series Unknown
Investors Number:
5
Last Funding Date:
2018-01-01
Industry:
PharmTech
Headquarters:
Newark, New Jersey, United States
Estimated Revenue:
$10M to $50M